Ifosfamide combined with toremifene in the treatment of non-small cell lung cancer

被引:2
作者
Salomaa, ER [1 ]
Liippo, K [1 ]
Ellmen, J [1 ]
Komi, J [1 ]
机构
[1] ORION CORP FARMOS,FIN-20101 TURKU,FINLAND
关键词
non-small cell lung cancer; chemotherapy; multi-drug resistance; toremifene; ifosfamide;
D O I
10.1016/S0169-5002(96)00613-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The efficacy and safety of toremifene-ifosfamide as a first-line chemotherapy in non-small cell lung cancer were assessed. Sixteen patients were treated with oral toremifene (420 mg on days 1-4 and 240 mg on day 5) followed by ifosfamide infusion 5 g/m(2) on day 5 every 3 weeks 1-6 times. Toremifene at the doses used did not enhance the effect or toxicity of ifosfamide in previously untreated non-small cell lung cancer patients. Copyright (C) 1996 Elsevier Science Ireland Ltd.
引用
收藏
页码:75 / 80
页数:6
相关论文
共 10 条
[1]  
Agresti A., 1990, CATEGORIAL DATA ANAL
[2]  
BAKER WJ, 1992, P AM SOC CLIN ONCOL, V11, P109
[3]   TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE [J].
DEGREGORIO, MW ;
FORD, JM ;
BENZ, CC ;
WIEBE, VJ .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1359-1364
[4]  
ETTINGER DS, 1989, SEMIN ONCOL S3, V16, P3
[5]  
KANGAS L, 1982, 11 OR CORP
[6]   CHEMOSENSITIZING EFFECT OF AN ANTIESTROGEN, TOREMIFENE, ON OVARIAN-CANCER [J].
MAENPAA, J ;
SIPILA, P ;
KANGAS, L ;
KARNANI, P ;
GRONROOS, M .
GYNECOLOGIC ONCOLOGY, 1992, 46 (03) :292-297
[7]  
OZOLS RF, 1988, P AM ASSOC CANC RES, V29, P526
[8]  
SHIN HJC, 1992, ANTICANCER RES, V12, P367
[9]  
VIRTANEN R, 1986, 3 OR CORP
[10]  
WURZ GT, 1992, CANC CHEMOTHER PHARM, V31, P412